NewslettersProstate Cell NewsRNA N6-Methyladenosine Modifications in Urological Cancers: From Mechanism to ApplicationBy lbeveridge - February 12, 2024048Scientists summarize the current evidence indicating that aberrant or dysregulated N6‐methyladenosine (m6A) modification is associated with urological cancer development, progression and prognosis.[Nature Reviews Urology]Abstract